Exane BNP Paribas Starts Clorox (CLX) at Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CLX Hot Sheet
Price: $88.00 -0.76%
Rating Summary:
1 Buy, 20 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
1 Buy, 20 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Exane BNP Paribas analyst Kevin Grundy initiates coverage on Clorox (NYSE: CLX) with a Underperform rating and a price target of $130.00.
For an analyst ratings summary and ratings history on Clorox click here. For more ratings news on Clorox click here.
Shares of Clorox closed at $136.64 yesterday.
You May Also Be Interested In
- Clorox names Fabian Garcia as CEO, effective January 2027
- H.C. Wainwright Assumes Agios Pharma (AGIO) at Buy
- Maxim Group Starts Nasus Pharma Ltd (NSRX) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
